Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Interleukin-13 Antagonist [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
LEBRIKIZUMAB 78 1 1.3% 27 0 49.2 yrs 53.2%
TRALOKINUMAB 50 1 2.0% 20 1 54.4 yrs 62.0%

Head-to-Head Comparisons

LEBRIKIZUMAB vs TRALOKINUMAB
← Back to Interleukin-13 Antagonist [EPC] Class side effects →